Search results
Theracurmin®: The Best just keeps getting Better
StreetInsider· 1 day agoTurmeric has been used medicinally to support health for over four thousand years in Asia. Curcumin, a constituent of turmeric, has been researched for its powerful contribution to Turmeric's ...
Advancements in protein engineering offer hope for cancer therapies
Medical Xpress· 3 days agoWhile cancer treatments have seen large improvements over the last decades, researchers are still...
Oral semaglutide could also help treat diabetes, cardiovascular issues
Medical News Today· 5 days agoA new clinical trial in Italy investigates the efficacy of oral semaglutide. Semaglutide and other...
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol...
Benzinga via AOL· 5 days agoWednesday, Adial Pharmaceuticals Inc. (NASDAQ:ADIL) announced that the first patient had been dosed...
SciTech Development secures additional funding for cancer trials
Clinical Trials Arena via Yahoo Finance· 5 days agoI trial for SCLC. A lead drug product of the company, ST-001 is a nanoparticulated formulation of...
Why 'food pairing' could be the key to better gut health
Yahoo Life UK· 4 days agoSo, avocado and tomatoes are an example of pairing fat with lycopenes. “Lycopene is an antioxidant...
Oral nucleoside antiviral is progressing toward future pandemic preparedness
Medical Xpress· 7 days agoSeveral researchers at the University of North Carolina at Chapel Hill's Gillings School of Global...
What's Really the Optimal Way to Use Progesterone?
Mercola· 5 days agoIn the U.S., 1 in 5 prescriptions are written for an off-label use.1 This means that a physician is prescribing a medication for a purpose that has not been officially approved by the U.S. Food ...
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have...
Morningstar· 7 days agoCARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly in-licensed drug eRapa for treating familial adenomatous ...
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus - Atea...
Benzinga· 5 days agoAtea Pharmaceuticals Inc AVIR announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combination study of bemnifosbuvir for hepatitis C virus (HCV). With ...
